Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 3 August 2026.

Announcements

5,264

Total raised

£158B

disclosed amounts

This month

£232M

raised so far

Series A
£9.0M

Breega and Mercia backed the InsurTech firm to accelerate growth in the UK and US markets.

"Send has the most advanced underwriting workbench on the market and a proven track record of improving underwriting processes. The funding will enable us to build on our first-mover advantage, scale up the business and establish Send as the market-leading underwriting software platform."
— Andy Moss, Co-founder and CEO
Series B
£15.5M

The Series B financing was led by Parkwalk Advisors and BGF to support the commercial scale-up of power transistors.

"CGD is poised to become one of the leaders in enabling a sustainable world. As we move to a net-zero carbon society with rapidly increasing levels of electrification, we need clean, renewable sources of electricity and more efficient conversion methods. GaN provides the optimum conversion solution, reducing power losses by more than 50% and increasing energy conversion efficiency to above 99%. To take just one application example, if all data centres were to adopt GaN, this would save 12.4TWh of electricity per year, or 9 million tons of CO2 – the equivalent of taking 1.9 million internal combustion engines vehicles off the road for a year *. Our ICeGaN™ GaN transistors – which are now in the hands of customers at scale – are amongst the most efficient devices of their type on the market. Our devices are also the easiest for designers to use."
— Giorgia Longobardi, CEO and Founder
Pre-Seed
£1.0M

The pre-seed round was led by Hambro Perks with backing from Fuel Ventures, 1818 Ventures, and APX.

"Like many people, I know first-hand the frustrations of trying to manage long-term conditions. Our goal is to give both patients and clinicians the tools and insights they need to have better conversations and make more informed treatment decisions together. The pilot in NHS England is our first step towards making Aide available to everyone with chronic illness."
— Ian Wharton, CEO